JNJ-3534

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameJNJ-3534
Drug Alias NameJNJ-3534
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoic acid receptor gamma inverse agonists
TargetsRetinoic acid receptor gamma
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPhenex Pharmaceuticals Ag
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPsoriasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A